Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits.
Level 5 - mechanism / opinion, no new human data
In vitro biophysical laboratory study (mechanism-based bench research without human subjects).
PubMed 11274207 · doi:10.1074/jbc.M100175200
What was done
Researchers investigated the coordination of Cu(2+) and Zn(2+) to amyloid-beta (Abeta) in aqueous solutions and negatively charged lipid environments. They analyzed the involvement of histidine residues (His6, His13, His14), the effect of histidine N(epsilon)2 methylation, metal-to-peptide molar ratios, and resulting secondary structure and membrane-penetration changes.
What was found
Coordination of metal ions involved His6, His13, and His14 in both aqueous and lipid environments. At Cu(2+)/peptide molar ratios >0.3, Abeta cooperatively coordinated a second Cu(2+) atom, an effect abolished by N(epsilon)2 histidine methylation. In negatively charged lipid environments, Cu(2+) or Zn(2+) addition induced a conformational transition from beta-sheet to alpha-helix, accompanied by peptide oligomerization and membrane penetration.
Why it matters
The findings provide a structural mechanism showing how copper and zinc ions can stabilize membrane-penetrating Abeta oligomers with superoxide dismutase-like bridging histidines, clarifying potential pathways for metal-driven neurotoxicity in Alzheimer's disease.
Limits
The study is entirely in vitro using synthetic peptide and model lipid systems, lacking validation in complex biological membranes, animal models, or human brain tissue. Quantitative binding affinities, kinetics, and downstream measures of cellular toxicity or reactive oxygen species generation were not reported in the abstract.
Cited by
- supports Research by Ashley Bush showed that amyloid-beta binds divalent metals including copper, zinc, and iron.